Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 438 days ( -0.88 % )
Last Price $34.49 0 %
High/ Low $34.49 - $34.49 0%
Chg 7 Days N/A $34.49 $34.49
Chg 30 Days N/A $34.49 $34.49
Chg 12 mos N/A $34.49 $34.49
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos N/A Width: 0.00000000 %
Pred. range - 3 mos $34.49 - $34.49 0 % - 0 %
Pred. range - 12 mos $34.49 - $34.49 0 % - 0 %
Short MA avg 3 mos Sell 0000-00-00 - N/A days
Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short MA avg 12 mos Sell 0000-00-00 - N/A days
Long MA avg 12 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 12 mos Sell 0000-00-00 - N/A days
Pivot Short Buy 2022-05-26 - 2 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Aimmune Therapeutics

Aimmune Therapeutics Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of desensitization treatments for peanut and other food allergies. Its Characterized Oral Desensitization Immunotherapy includes AR101, a product in Phase 3 registration trial for the treatment of peanut allergy in children and adults. The company was formerly known as Allergen Research Corporation and changed its name to Aimmune Therapeutics, Inc. ... AIMT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT